Splice site, frameshift, and chimeric GFAP mutations in Alexander disease

Daniel Flint, Rong Li, Lital S. Webster, Sakkubai Naidu, Edwin Kolodny, Alan Percy, Marjo van der Knaap, James M. Powers, John F. Mantovani, Josef Ekstein, James E. Goldman, Albee Messing, Michael Brenner

Research output: Contribution to journalArticle

Abstract

Alexander disease (AxD) is a usually fatal astrogliopathy primarily caused by mutations in the gene encoding glial fibrillary acidic protein (GFAP), an intermediate filament protein expressed in astrocytes. We describe three patients with unique characteristics, and whose mutations have implications for AxD diagnosis and studies of intermediate filaments. Patient 1 is the first reported case with a noncoding mutation. The patient has a splice site change producing an in-frame deletion of exon 4 in about 10% of the transcripts. Patient 2 has an insertion and deletion at the extreme end of the coding region, resulting in a short frameshift. In addition, the mutation was found in buccal DNA but not in blood DNA, making this patient the first reported chimera. Patient 3 has a single-base deletion near the C-terminal end of the protein, producing a short frameshift. These findings recommend inclusion of intronic splice site regions in genetic testing for AxD, indicate that alteration of only a small fraction of GFAP can produce disease, and provide caution against tagging intermediate filaments at their C-terminal end for cell biological investigations.

Original languageEnglish (US)
Pages (from-to)1141-1148
Number of pages8
JournalHuman Mutation
Volume33
Issue number7
DOIs
StatePublished - Jul 2012

Fingerprint

Alexander Disease
Glial Fibrillary Acidic Protein
Mutation
Intermediate Filaments
Intermediate Filament Proteins
Cheek
DNA
Genetic Testing
Astrocytes
Exons

Keywords

  • Aggregate
  • Alexander disease
  • Astrocyte
  • Chimera
  • GFAP
  • Leukodystrophy

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Flint, D., Li, R., Webster, L. S., Naidu, S., Kolodny, E., Percy, A., ... Brenner, M. (2012). Splice site, frameshift, and chimeric GFAP mutations in Alexander disease. Human Mutation, 33(7), 1141-1148. https://doi.org/10.1002/humu.22094

Splice site, frameshift, and chimeric GFAP mutations in Alexander disease. / Flint, Daniel; Li, Rong; Webster, Lital S.; Naidu, Sakkubai; Kolodny, Edwin; Percy, Alan; van der Knaap, Marjo; Powers, James M.; Mantovani, John F.; Ekstein, Josef; Goldman, James E.; Messing, Albee; Brenner, Michael.

In: Human Mutation, Vol. 33, No. 7, 07.2012, p. 1141-1148.

Research output: Contribution to journalArticle

Flint, D, Li, R, Webster, LS, Naidu, S, Kolodny, E, Percy, A, van der Knaap, M, Powers, JM, Mantovani, JF, Ekstein, J, Goldman, JE, Messing, A & Brenner, M 2012, 'Splice site, frameshift, and chimeric GFAP mutations in Alexander disease', Human Mutation, vol. 33, no. 7, pp. 1141-1148. https://doi.org/10.1002/humu.22094
Flint, Daniel ; Li, Rong ; Webster, Lital S. ; Naidu, Sakkubai ; Kolodny, Edwin ; Percy, Alan ; van der Knaap, Marjo ; Powers, James M. ; Mantovani, John F. ; Ekstein, Josef ; Goldman, James E. ; Messing, Albee ; Brenner, Michael. / Splice site, frameshift, and chimeric GFAP mutations in Alexander disease. In: Human Mutation. 2012 ; Vol. 33, No. 7. pp. 1141-1148.
@article{a31dbe86d8ba4af0a037f9a5fbba2227,
title = "Splice site, frameshift, and chimeric GFAP mutations in Alexander disease",
abstract = "Alexander disease (AxD) is a usually fatal astrogliopathy primarily caused by mutations in the gene encoding glial fibrillary acidic protein (GFAP), an intermediate filament protein expressed in astrocytes. We describe three patients with unique characteristics, and whose mutations have implications for AxD diagnosis and studies of intermediate filaments. Patient 1 is the first reported case with a noncoding mutation. The patient has a splice site change producing an in-frame deletion of exon 4 in about 10{\%} of the transcripts. Patient 2 has an insertion and deletion at the extreme end of the coding region, resulting in a short frameshift. In addition, the mutation was found in buccal DNA but not in blood DNA, making this patient the first reported chimera. Patient 3 has a single-base deletion near the C-terminal end of the protein, producing a short frameshift. These findings recommend inclusion of intronic splice site regions in genetic testing for AxD, indicate that alteration of only a small fraction of GFAP can produce disease, and provide caution against tagging intermediate filaments at their C-terminal end for cell biological investigations.",
keywords = "Aggregate, Alexander disease, Astrocyte, Chimera, GFAP, Leukodystrophy",
author = "Daniel Flint and Rong Li and Webster, {Lital S.} and Sakkubai Naidu and Edwin Kolodny and Alan Percy and {van der Knaap}, Marjo and Powers, {James M.} and Mantovani, {John F.} and Josef Ekstein and Goldman, {James E.} and Albee Messing and Michael Brenner",
year = "2012",
month = "7",
doi = "10.1002/humu.22094",
language = "English (US)",
volume = "33",
pages = "1141--1148",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "Wiley-Liss Inc.",
number = "7",

}

TY - JOUR

T1 - Splice site, frameshift, and chimeric GFAP mutations in Alexander disease

AU - Flint, Daniel

AU - Li, Rong

AU - Webster, Lital S.

AU - Naidu, Sakkubai

AU - Kolodny, Edwin

AU - Percy, Alan

AU - van der Knaap, Marjo

AU - Powers, James M.

AU - Mantovani, John F.

AU - Ekstein, Josef

AU - Goldman, James E.

AU - Messing, Albee

AU - Brenner, Michael

PY - 2012/7

Y1 - 2012/7

N2 - Alexander disease (AxD) is a usually fatal astrogliopathy primarily caused by mutations in the gene encoding glial fibrillary acidic protein (GFAP), an intermediate filament protein expressed in astrocytes. We describe three patients with unique characteristics, and whose mutations have implications for AxD diagnosis and studies of intermediate filaments. Patient 1 is the first reported case with a noncoding mutation. The patient has a splice site change producing an in-frame deletion of exon 4 in about 10% of the transcripts. Patient 2 has an insertion and deletion at the extreme end of the coding region, resulting in a short frameshift. In addition, the mutation was found in buccal DNA but not in blood DNA, making this patient the first reported chimera. Patient 3 has a single-base deletion near the C-terminal end of the protein, producing a short frameshift. These findings recommend inclusion of intronic splice site regions in genetic testing for AxD, indicate that alteration of only a small fraction of GFAP can produce disease, and provide caution against tagging intermediate filaments at their C-terminal end for cell biological investigations.

AB - Alexander disease (AxD) is a usually fatal astrogliopathy primarily caused by mutations in the gene encoding glial fibrillary acidic protein (GFAP), an intermediate filament protein expressed in astrocytes. We describe three patients with unique characteristics, and whose mutations have implications for AxD diagnosis and studies of intermediate filaments. Patient 1 is the first reported case with a noncoding mutation. The patient has a splice site change producing an in-frame deletion of exon 4 in about 10% of the transcripts. Patient 2 has an insertion and deletion at the extreme end of the coding region, resulting in a short frameshift. In addition, the mutation was found in buccal DNA but not in blood DNA, making this patient the first reported chimera. Patient 3 has a single-base deletion near the C-terminal end of the protein, producing a short frameshift. These findings recommend inclusion of intronic splice site regions in genetic testing for AxD, indicate that alteration of only a small fraction of GFAP can produce disease, and provide caution against tagging intermediate filaments at their C-terminal end for cell biological investigations.

KW - Aggregate

KW - Alexander disease

KW - Astrocyte

KW - Chimera

KW - GFAP

KW - Leukodystrophy

UR - http://www.scopus.com/inward/record.url?scp=84861873720&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861873720&partnerID=8YFLogxK

U2 - 10.1002/humu.22094

DO - 10.1002/humu.22094

M3 - Article

VL - 33

SP - 1141

EP - 1148

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 7

ER -